English | 中文版 | 手機(jī)版 企業(yè)登錄 | 個人登錄 | 郵件訂閱
當(dāng)前位置 > 首頁 > 技術(shù)文章 > 膠原酶的類型和應(yīng)用及其組織解離方法介紹

膠原酶的類型和應(yīng)用及其組織解離方法介紹

瀏覽次數(shù):504 發(fā)布日期:2024-7-5  來源:MedChemExpress (MCE)
 

膠原酶 (Collagenase),化學(xué)名為膠原蛋白水解酶,是從溶組織梭菌芽孢桿菌提取制備而成,能夠特異性識別膠原蛋白中的 Pro-X-Gly-Pro 序列,并切割該序列中的中性氨基酸 (X) 和甘氨酸 (Gly) 之間的肽鍵,常用于原代細(xì)胞制備[1][2]。不同類型膠原酶的應(yīng)用為大家整理在下面啦~

表 1. 膠原酶的類型及應(yīng)用。  







 


圖 1. 從固體組織制備單細(xì)胞懸浮液的關(guān)鍵步驟[3]。

 膠原酶配制

向 100 mg 膠原酶中加入 4.5 mL HBSS,震蕩使其充分溶解, 0.22 μm 濾膜過濾除菌后,立即使用或分裝成小份量,于 -20°C 避光凍存,使用前在冰上解凍,避免反復(fù)凍融[4]。

 組織分離

1、從生物體中解剖組織后,使用培養(yǎng)基/PBS/HBSS 清洗組織,隨后用無菌手術(shù)刀或剪刀將組織切成小的組織塊,HBSS 洗滌組織塊[5][6]。

2、加入足量 HBSS,使其浸沒組織塊,并加入膠原酶至需要的工作濃度,于 37℃ 孵育。

表 2. 不同組織樣本解離方案。


3、已分散開的細(xì)胞可使用細(xì)胞過濾器/尼龍網(wǎng)篩得,收集備用。

4、使用不含膠原酶的 HBSS 或培養(yǎng)基洗滌收集的細(xì)胞數(shù)次。

5、預(yù)冷的細(xì)胞培養(yǎng)液重懸細(xì)胞[13]。

 實(shí)驗技巧

 

MCE 除了膠原酶外,還提供如胰酶、分散酶、重組胰酶消化液等,均可應(yīng)用于細(xì)胞消化及組織解離。 








[1] Zhewen Hu,et al. Novel strategy for primary epithelial cell isolation: Combination of hyaluronidase and collagenase I.Cell Prolif. 2023 Jan;56(1):e13320.

[2] Meital Charni-Natan,et al. Protocol for Primary Mouse Hepatocyte Isolation.STAR Protoc. 2020 Aug 13;1(2):100086.

[3] Andrew Reichard,et al.Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry. Cytometry A. 2019 Feb;95(2):219-226.

[4] Manouela V. Valtcheva,et al. Surgical extraction of human dorsal root ganglia from organ donors and preparation of primary sensory neuron cultures. Nat Protoc. 2016 October ; 11(10): 1877-1888.

[5] Hussein Shoaito,et al. The Role of Peroxisome Proliferator–Activated Receptor Gamma (PPARγ) in Mono(2-ethylhexyl) Phthalate (MEHP)-Mediated Cytotrophoblast Differentiation.Environ Health Perspect. 2019 Feb;127(2):27003.

[6] Zhewen Hu,et al. Novel strategy for primary epithelial cell isolation: Combination of hyaluronidase and collagenase I. Cell Prolif. 2023 Jan;56(1):e13320.

[7] Anna A. Nushtaeva ,et al. Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice. Cancer Cell International volume 19, Article number: 46 (2019).

[8] Chaojun Tang ,et al. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.Theranostics. 2021 Oct 3;11(20):9791-9804.

[9] Miguel F. Diaz ,et al. Bone marrow stromal cell therapy improves survival after radiation injury but does not restore endogenous hematopoiesis.Scientific Reports. (2020) 10:22211

[10] Nan Mei ,et al. The genotoxicity of acrylamide and glycidamide in big blue rats.Toxicol Sci. 2010 Jun;115(2):412-21.

[11] Chenwei Li ,et al. Identification of Pancreatic Cancer Stem Cells.Cancer Res (2007) 67 (3): 1030-1037.

[12] Suzanne Bertera ,et al. Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice.Front. Med. 8:660877.

[13] Akihito Harusato,et al. Macrophage Isolation from the Mouse Small and Large Intestine.Methods Mol Biol. 2016:1422:171-80. 

來源:上海皓元生物醫(yī)藥科技有限公司
聯(lián)系電話:021-58955995
E-mail:sales@medchemexpress.cn

標(biāo)簽: 膠原酶 組織解離
用戶名: 密碼: 匿名 快速注冊 忘記密碼
評論只代表網(wǎng)友觀點(diǎn),不代表本站觀點(diǎn)。 請輸入驗證碼: 8795
Copyright(C) 1998-2024 生物器材網(wǎng) 電話:021-64166852;13621656896 E-mail:info@bio-equip.com